(임상정보)이상지혈증 치료의 새로운 지평, Rosuvastatin(Crestor)

참고문헌 (35)

1. McTaggart F, "Preclinical and clinical pharmacology of rosuvastatin,a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor", 87, pp.28~32 (2001)
2. , 2000, 151~41
3. Nezasa K, "Liver-specific distribution of rosuvastatin in rats:comparison with pravastatin and simvastatin", 30, pp.1158~1163 (2002)
4. Chapman MJ, "Optimizing the pharmacology of statins: characteristics of rosuvastatin", 2, pp.33~36 (2002)
5. , 2001, 88~
6. Watanabe M, "Synthesis and biological activity of methanesulfonamide pyrimidine- and N-methanesulfonyle pyrrole-substituted 3,5-dihydroxy-6-heptenoates,a novel series of HMG-CoA reductase inhibitors", 5, pp.437~444 (1997)
7. Martin PD, "Pharmacodynamic effects and pharmacokinetics of a new HMG-CoA reductase inhibitor,rosuvastatin,after morning or evening administration in healthy volunteers", 54, pp.472~477 (2002)
8. LaRosa JC, "Pleiotropic effects of statins and their clinical significance", 88, pp.291~293 (2001)
9. Bonetti PO, "Statin effects beyond lipid lowering - are they clinically relevant?", 24, pp.225~248 (2003)
10. ., , 2002, ~
11. Laufs U, "The hydrophilic HMG-CoA reductase inhibitor rosuvastatin regulates endothelial NO synthase and ischaemic stroke in vivo [abstract no", pp.19~
12. Hermann M, "Rosuvastatin improves endothelial dysfunction in a rat model of normocholesterolemic mineralocorticoid hyperpresented tension", 40, pp.439~440 (2002)
13. Jones SP, "Direct vascular and cardioprotective effects of rosuvastatin,a new HMG-CoA reductase inhibitor", 40, pp.1172~1178 (2002)
14. Stalker TJ, "A new HMG-CoA reductase inhibitor,rosuvastatin,exerts anti-inflammatory effects on the microvascular endothelium:the role of mevalonic acid", 133, pp.406~412 (2001)
15. Nangle MR, "Effects of rosuvastatin on nitric oxide-dependent function in aorta and corpus cavernosum of diabetic mice:relationship to cholesterol biosynthesis pathway inhibition and lipid lowering", 52, pp.2396~2402 (2003)
16. ., , 2003, 303~
17. ., , 2003, 308~
18. Werner N, "Bone marrow-derived progenitor cells modulate vascular reendothelialization and neointimal formation:effect of 3-hydrox- hypercholestery-3-methylglutaryl coenzyme a reductase inhibition", 22, pp.1567~1572 (2002)
19. Kleemann R, "Rosuvastatin reduces atherosclerosis development beyond and independent of its plasma cholesterol-lowering effect rosuvastain APOE*3-Leiden transgenic mice:evidence for antiinflammatory effects of rosuvastatin", 108, pp.1368~1374 (2003)
20. Susic D, "Beneficial pleiotropic vascular effects of rosuvastatin in two hypertensive models", 42, pp.1091~1097 (2003)
21. ., , 2003, 312~
22. Ikeda Y, "Rosuvastatin,a new HMG-CoA reductase inhibitor,protects ischemic reperfused myocardium in normocholesterolemic rats", 41, pp.649~656 (2003)
23. , 2003, 376~
24. ., , 2000, 196~
25. Martin PD, "No effect of age or gender on the pharmacokinetics of rosuvastatin:a new HMG-CoA reductase inhibitor", 42, pp.1116~1121 (2002)
26. Martin PD, "An open-label,randomized,three-way crossover trial of the effects of coadministration of rosuvastatin and fenofibrate on the pharmacokinetic properties of rosuvastatin and fenofibric acid in healthy male volunteers", 25, pp.459~471 (2003)
27. AstraZeneca, "Crestor (rosuvastatin calcium) US prescribing information" (2003), Astra Zeneca Pharmaceuticals LP
28. Brown WV, "Efficacy and safety of rosuvastatin compared with pravastatin and simvastatin in patients with hypercholesteryolemia:a randomized,double-blind,52-week trial", 144, pp.1036~1043 (2002)
29. Davidson M, "Comparison of effects on low-density lipoprotein cholesterol and high-density lipoprotein cholesterol with rosuvastaintin versus atorvastatin in patients with type IIa or IIb hypercholesterolemia", 89, pp.268~275 (2002)
30. Olsson AG, "Effects of rosuvastatin and atorvastatin compared over 52 weeks of treatment in patients with hypercholesterolemia Rosuvastatin Investigators Group", 144, pp.1044~1051 (2002)
31. Paoletti R, "Rosuvastatin demonstrates greater reduction of low-density lipoprotein cholesterol compared with pravastatin and simvastaclertin in hypercholesterolaemic patients:a randomized,double-blind study", 8, pp.383~390 (2001)
32. Schuster H. I, "Effects of switching to rosuvastatin from atorvastatin or other statins on achievement of international low-density lipoprotein cholesterol goals: MERCURY I trial", 41, pp.227~228 (2003)
33. Capuzzi DM, "Beneficial effects of rosuvastatin alone and in combination with extended-release niacin in patients with a combined hyperlipidemia and low high-density lipoprotein cholesterol levels", 91, pp.1304~1310 (2003)
34. Brewer HB Jr, "Benefit-risk assessment of rosuvastatin 10 to 40 milligrams", 92, pp.23~29 (2003)
35. . Circulation [online, , ~

관련 논문AI추천